Tejaswini Kulkarni

2.1k total citations
58 papers, 829 citations indexed

About

Tejaswini Kulkarni is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Tejaswini Kulkarni has authored 58 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 11 papers in Pathology and Forensic Medicine and 6 papers in Molecular Biology. Recurrent topics in Tejaswini Kulkarni's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Systemic Sclerosis and Related Diseases (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Tejaswini Kulkarni is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Systemic Sclerosis and Related Diseases (11 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers). Tejaswini Kulkarni collaborates with scholars based in United States, United Kingdom and Switzerland. Tejaswini Kulkarni's co-authors include Victor J. Thannickal, Veena B. Antony, João A. de Andrade, Tracy Luckhardt, Steven R. Duncan, Ranu Surolia, Amit Gaggar, Philip O’Reilly, Gang Liu and Fu Jun Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Tejaswini Kulkarni

47 papers receiving 821 citations

Peers

Countries citing papers authored by Tejaswini Kulkarni

Since Specialization

Citations

This map shows the geographic impact of Tejaswini Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tejaswini Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tejaswini Kulkarni more than expected).

Fields of papers citing papers by Tejaswini Kulkarni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tejaswini Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tejaswini Kulkarni. The network helps show where Tejaswini Kulkarni may publish in the future.

Co-authorship network of co-authors of Tejaswini Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Tejaswini Kulkarni. A scholar is included among the top collaborators of Tejaswini Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tejaswini Kulkarni. Tejaswini Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deupirfenidone Compared to Placebo and Pirfenidone in Idiopathic Pulmonary Fibrosis: ELEVATE IPF Phase 2b Trial 2025 ·American Journal of Respiratory and Critical Care Medicine ·Toby M. Maher, Miguel Bergna, Amy Hajari Case, Won-Il Choi, Mark J. Hamblin, Tejaswini Kulkarni, (unknown), Ioannis Tomos, Αrgyris Τzouvelekis, David A. Golod, Eric Elenko, (unknown), Camilla S. Graham, Jin Woo Song, (unknown)	1
2	TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity 2025 ·Nature Communications ·Huachun Cui, Sami Banerjee, Na Xie, Musaddique Hussain, Ashish Jaiswal, Hongli Liu, Tejaswini Kulkarni, Veena B. Antony, Rui-Ming Liu, Marco Colonna, (unknown)	5
3	Caring for Rural Patients With Interstitial Lung Disease 2025 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rebecca Bascom, (unknown), Mary Beth Scholand, (unknown), Anoop M. Nambiar, Sonye K. Danoff, Franck Rahaghi, Tejaswini Kulkarni, (unknown)	0
4	Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study 2025 ·BMC Pulmonary Medicine ·Camilla S. Graham, Brad Bisson, (unknown), (unknown), Frank B. Salisbury, Lisa Lancaster, Tejaswini Kulkarni	0
5	Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis 2024 ·Respiratory Research ·M. G. Sridhar, Sandeep Bodduluri, (unknown), (unknown), (unknown), João A. de Andrade, Young-il Kim, Tracy Luckhardt, Merry‐Lynn McDonald, Tejaswini Kulkarni	11
6	Objective measurement of cough in pulmonary fibrosis: a cohort study – ImpaCT 2024 ·ERJ Open Research ·(unknown), Simon P. Hart, Robert J. Kaner, Tejaswini Kulkarni, Lutz Wollin, Carl Coeck, Richard Vinisko, (unknown), Marlies Wijsenbeek	0
7	Leveraging Carbon Markets for Cost-Efficient Emissions Reductions in India: Practical Recommendations for the Design and Implementation of an Effective Carbon Market 2023 ·(unknown), (unknown), Shubhangi Gupta, (unknown), Tejaswini Kulkarni	2
8	Citrullinated vimentin mediates development and progression of lung fibrosis 2021 ·Science Translational Medicine ·Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Gang Liu, Tejaswini Kulkarni, Adriana V. F. Massicano, James A. Mobley, Santanu Mondal, João A. de Andrade, Scott A. Coonrod, Paul R. Thompson, Keith Wille, Suzanne E. Lapi, Mohammad Athar, Victor J. Thannickal, A. Brent Carter, Veena B. Antony	86
9	Citrullinated Vimentin Generated by Cadmium/Carbon Black Exposure Mediates Lung Fibrosis 2020 ·(unknown), Ranu Surolia, H. Li, (unknown), Gang Liu, Adriana V. F. Massicano, Tejaswini Kulkarni, James A. Mobley, João A. de Andrade, Keith Wille, Mohammad Athar, Suzanne E. Lapi, (unknown), (unknown), Veena B. Antony	1
10	Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Who to Treat, How to Treat 2019 ·PubMed ·Tejaswini Kulkarni, Steven R. Duncan	5
11	The senescence-associated matricellular protein CCN1 in plasma of human subjects with idiopathic pulmonary fibrosis 2019 ·Respiratory Medicine ·Tejaswini Kulkarni, Ashish Kurundkar, Young-il Kim, João A. de Andrade, Tracy Luckhardt, Victor J. Thannickal	17
12	Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis 2017 ·The Journal of Immunology ·Fu Jun Li, Ranu Surolia, Huashi Li, Zheng Wang, Tejaswini Kulkarni, Gang Liu, João A. de Andrade, Daniel J. Kass, Victor J. Thannickal, Steven R. Duncan, Veena B. Antony	65
13	DNA-based culture-independent analysis detects the presence of group a streptococcus in throat samples from healthy adults in Japan 2016 ·BMC Microbiology ·Tejaswini Kulkarni, Chihiro Aikawa, Takashi Nozawa, Kazunori Murase, Fumito Maruyama, Ichirô Nakagawa	2
14	Matrix Remodeling in Pulmonary Fibrosis and Emphysema 2016 ·American Journal of Respiratory Cell and Molecular Biology ·Tejaswini Kulkarni, Philip O’Reilly, Veena B. Antony, Amit Gaggar, Victor J. Thannickal	92
15	Extracorporeal membrane oxygenation in adults: A practical guide for internists 2016 ·Cleveland Clinic Journal of Medicine ·Tejaswini Kulkarni, Nirmal Sharma, Enrique Diaz‐Guzman	19
16	A bundled care approach to patients with idiopathic pulmonary fibrosis improves transplant-free survival 2016 ·Respiratory Medicine ·Tejaswini Kulkarni, John O. Willoughby, (unknown), Young-il Kim, Rekha Ramachandran, C. Bruce Alexander, Tracy Luckhardt, Victor J. Thannickal, João A. de Andrade	11
17	Safety of Flexible Bronchoscopy in Critically ill Adult Patients Supported With Extracorporeal Membrane Oxygenation 2015 ·CHEST Journal ·Timothy R. Peters, Keith Wille, Tejaswini Kulkarni, Enrique Diaz‐Guzman, Nirmal Sharma	2
18	Oxidative Modifications of Protein Tyrosyl Residues Are Increased in Plasma of Human Subjects with Interstitial Lung Disease 2015 ·American Journal of Respiratory and Critical Care Medicine ·Subramaniam Pennathur, Anuradha Vivekanandan‐Giri, Morgan L. Locy, Tejaswini Kulkarni, Degui Zhi, Lixia Zeng, Jaeman Byun, João A. de Andrade, Victor J. Thannickal	27
19	Characteristics of Patients with Pulmonary Venoocclusive Disease Awaiting Transplantation 2014 ·Annals of the American Thoracic Society ·Keith Wille, Nirmal Sharma, Tejaswini Kulkarni, Matthew R. Lammi, Joseph B. Barney, (unknown), Ryan S. Cantor, David C. Naftel, Enrique Diaz‐Guzman, David C. McGiffin	22
20	Loss of Salmeterol Bronchoprotection against Exercise in Relation to ADRB2 Arg16Gly Polymorphism and Exhaled Nitric Oxide 2013 ·American Journal of Respiratory and Critical Care Medicine ·Matteo Bonini, Perdita Permaul, Tejaswini Kulkarni, Shamsah Kazani, (unknown), Christine A. Sorkness, Michael E. Wechsler, Elliot Israel	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact